Grant: Master's Award: Canada Graduate Scholarships

Since the Canadian legalization of recreational cannabis, millions of Canadians (15 or older) have used, or are continuously using cannabis. The popularity of cannabis has risen with government acceptance, ease of legal access, and widely known potential health benefits including alleviation of chronic and pelvic pain, headaches, cramping, gastrointestinal distress, and feelings of anxiousness and depressed mood. We know little, however, on how cannabis use may impact women experiencing their menstrual cycles. Moreover, there is scarce research on how potential self-medicative practices might develop in individuals experiencing mood-related and physical distress as of consequence of their menstrual cycle. The purpose of this study is to determine whether cannabis frequency, quantity, and mode of intake are associated with the physical or affective symptoms experienced during the menstrual cycle. Of secondary interest is the knowledge of those using cannabis. Menstrual cycle distress (e.g., depressed mood, tension, irritability, cramping) is a common occurrence in women following puberty. However, for a striking number of individuals, their distress is incapacitating, stopping them from attending social gatherings, completing daily routines, and attending work. Many women experiencing depressed and anxious feelings, or physical pain seek alleviation of these symptoms through treatment. Some comfort has been identified as achievable with pain killers, homeopathic remedies, and topical creams. The existing literature also suggests that women might turn to cannabis for relief of menstrual cycle symptoms. The proposed study could inform diagnosis and treatment of menstrual cycle distress where cannabis is a treatment option, as well as implications for substance misuse.